Mesenchymal Stem Cells - Interest Group
References (continued):

  • Gojo S, Gojo N, Takeda Y et al. In vivo cardiovasculogenesis by direct injection of isolated
    adult mesenchymal stem cells. Exp Cell Res 2003;288:51–59.

  • Liechty KW, MacKenzie TC, Shaaban AF et al. Human mesenchymal stem cells engraft and
    demonstrate site-specific differentiation after in utero transplantation in sheep. Nat Med
    2000;6:1282–1286.

  • Barbash IM, Chouraqui P, Baron J et al. Systemic delivery of bone marrow-derived
    mesenchymal stem cells to the infarcted myocardium: Feasibility, cell migration, and body
    distribution. Circulation 2003;108:863–868.

  • Gao J, Dennis JE, Muzic RF et al. The dynamic in vivo distribution of bone marrow-derived
    mesenchymal stem cells after infusion. Cells Tissues Organs 2001;169:12–20.

  • Mahmood A, Lu D, Lu M et al. Treatment of traumatic brain injury in adult rats with
    intravenous administration of human bone marrow stromal cells. Neurosurgery 2003;53:
    697–702.

  • Chen J, Li Y, Wang L et al. Therapeutic benefit of intravenous administration of bone
    marrow stromal cells after cerebral ischemia in rats. Stroke 2001;32:1005–1011.

  • Wu GD, Nolta JA, Jin YS et al. Migration of mesenchymal stem cells to heart allografts
    during chronic rejection. Transplantation 2003;75:679–685.

  • Ortiz LA, Gambelli F, McBride C et al. Mesenchymal stem cell engraftment in lung is
    enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc Natl
    Acad Sci U S A 2003;100:8407–8411.

  • Horwitz EM, Prockop DJ, Fitzpatrick LA et al. Transplantability and therapeutic effects of bone
    marrow-derived mesenchymal cells in children with osteogenesis imperfecta. Nat Med 1999;
    5:309–313.